Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs ; day:07 ; month:09 ; year:2021 ; extent:1
ChemMedChem ; (07.09.2021) (gesamt 1)
- Creator
-
Ciaffaglione, Valeria
Modica, Maria N.
Pittalà, Valeria
Romeo, Giuseppe
Salerno, Loredana
Intagliata, Sebastiano
- DOI
-
10.1002/cmdc.202100473
- URN
-
urn:nbn:de:101:1-2021090715133876426495
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ciaffaglione, Valeria
- Modica, Maria N.
- Pittalà, Valeria
- Romeo, Giuseppe
- Salerno, Loredana
- Intagliata, Sebastiano
Other Objects (12)
Molecular Basis of Drug Interactions of Methotrexate, Cyclophosphamide and 5-Fluorouracil as Chemotherapeutic Agents in Cancer
Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5‐Fluorouracil and Imidazole‐Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28
"Prodrugs" glycerolipidiques comme systeme pharmaceutique
Synthese und Untersuchung von Nucleosiddiphosphat Prodrugs
Synthese von acyclischen Phosphonat-Diphosphat-Prodrugs
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]
Hochdosierte 5-Fluorouracil-Therapie [Fluorouracil-Therapie] bei kolorektelen Tumoren
Molecular Basis of Drug Interactions of Methotrexate, Cyclophosphamide and 5-Fluorouracil as Chemotherapeutic Agents in Cancer
Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5‐Fluorouracil and Imidazole‐Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28
"Prodrugs" glycerolipidiques comme systeme pharmaceutique
Synthese und Untersuchung von Nucleosiddiphosphat Prodrugs
Synthese von acyclischen Phosphonat-Diphosphat-Prodrugs
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]
Hochdosierte 5-Fluorouracil-Therapie [Fluorouracil-Therapie] bei kolorektelen Tumoren
Molecular Basis of Drug Interactions of Methotrexate, Cyclophosphamide and 5-Fluorouracil as Chemotherapeutic Agents in Cancer
Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5‐Fluorouracil and Imidazole‐Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28
"Prodrugs" glycerolipidiques comme systeme pharmaceutique
Synthese und Untersuchung von Nucleosiddiphosphat Prodrugs
Synthese von acyclischen Phosphonat-Diphosphat-Prodrugs
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]